bioRxivPhysiologyPreprint
Exogenous mitochondrial transfer increases energy expenditure and attenuates adiposity gains in mice with diet-induced obesity
M. Namwanje, S. Mazumdar, A. Stayton, P. S. Patel, C. Watkins, C. White, C. Brown, J. D. Eason, K. Mozhui, C. Kuscu, N. Pabla, E. J. Stephenson, A. Bajwa
Abstract
Obesity is associated with chronic multi-system bioenergetic stress that may be improved by increasing the number of healthy mitochondria available across organ systems. However, treatments capable of increasing mitochondrial content are generally limited to endurance exercise training paradigms, which are not always sustainable long-term, let alone feasible for many patients with obesity. Recent studies have shown that local transfer of exogenous mitochondria from healthy donor tissues can improve bioenergetic outcomes and alleviate the effects of tissue injury in recipients with organ specific disease. Thus, the aim of this project was to determine the feasibility of systemic mitochondrial transfer for improving energy balance regulation in the setting of diet-induced obesity. We found that transplantation of mitochondria from lean mice into mice with diet-induced obesity attenuated adiposity gains by increasing energy expenditure and promoting the mobilization and oxidation of lipids. Additionally, mice that received exogenous mitochondria demonstrated improved glucose uptake, greater insulin responsiveness, and complete reversal of hepatic steatosis. These changes were, in part, driven by adaptations occurring in white adipose tissue. Together, these findings are proof-of-principle that mitochondrial transplantation is an effective therapeutic strategy for limiting the deleterious metabolic effects of diet-induced obesity in mice.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Inhibition of mammalian mtDNA transcription paradoxically activates liver fatty acid oxidation to reverse diet-induced hepatosteatosis and obesity
S. Jiang, T. Yuan, … N.-G. Larsson·bioRxiv·Sep 22, 2023
- In vitro model of human subcutaneous adipocyte spheroids for studying mitochondrial dysfunction and mitochondria activating compounds
Anita Wagner, Juulia H. Lautaoja-Kivipelto, … Eija Pirinen·iSciencePeer-reviewed·Dec 29, 2025
- Buenos Aires, June 2021Inhibition of Mitochondrial Fission by Drp-1 Blockade by Short-Term Leptin and Mdvi-1 Treatment Improves White Adipose Tissue Abnormalities in Obesity and Diabetes
Paola Vanesa Finocchietto, H. Perez, … M.C. Carreras·Pharmacological ResearchPeer-reviewed·Dec 9, 2021
- Male obesity causes adipose mitochondrial dysfunction in F1 progeny via a let-7-DICER axis.
Chien Hsiang Huang, Joo-Hyun Park, … Jan‐Wilhelm Kornfeld·Nature CommunicationsPeer-reviewed·Feb 24, 2026
- Obesity causes irreversible mitochondria failure in visceral adipose tissue despite successful anti-obesogenic lifestyle-based interventions
Alba Gonzalez-Franquesa, Pau Gama-Perez, … Laur·Redox BiologyPeer-reviewed·Aug 1, 2022
- Reducing the mitochondrial oxidative burden alleviates lipid-induced muscle insulin resistance in humans
M. Fiorenza, J. Onslev, … J. Bangsbo·bioRxiv·Apr 10, 2023